American Vietnamese Biotech Incorporation (HNX:AMV) announced a private placement on January 3, 2017. The transaction was approved by the company’s board of directors. The transaction is subject to approval of the shareholders at the extraordinary general mandate 2017 which has the record date as January 20, 2017.